Skip to main content

Find Clinical Trials

Home
Conditions
Hypersensitivity, Immediate

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,736 public trials 631 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis

NCT00407979

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +11 more
Locations: University of California, San Diego San Diego, California, United States

National Jewish Health Denver, Colorado, United States

View Trial Details

Completed

A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function

NCT01287065

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Wellington, New Zealand

View Trial Details

Completed

Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema

NCT02357940

Conditions: Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations: Hill-top Research, Inc St. Petersburg, Florida, United States

TKL Research Inc. Fair Lawn, New Jersey, United States

View Trial Details

Completed

Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen

NCT03014661

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: Saarland University Hospital. Department of Dermatology Homburg, Saarland, Germany

View Trial Details

Completed

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

NCT01436110

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Rolling Hills Estates, California, United States

GSK Investigational Site Sacramento, California, United States

GSK Investigational Site San Jose, California, United States

View all 42 locations

View Trial Details

Completed

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

NCT01573767

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Mobile, Alabama, United States

GSK Investigational Site Little Rock, Arkansas, United States

GSK Investigational Site Huntington Beach, California, United States

View all 120 locations

View Trial Details

Completed

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry

NCT01498653

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Guangzhou, Guangdong, China

GSK Investigational Site Changsha, Hunan, China

GSK Investigational Site Shenyang, Liaoning, China

GSK Investigational Site Shenyang, Liaoning, China

View all 24 locations

View Trial Details

Completed

To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma

NCT01808339

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Randwick, New South Wales, Australia

View Trial Details

Completed

A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)

NCT01957202

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +9 more
Locations: GSK Investigational Site Vienna, Austria

View Trial Details

Completed

Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents

NCT01431950

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Long Beach, California, United States

GSK Investigational Site Newport Beach, California, United States

GSK Investigational Site Colorado Springs, Colorado, United States

GSK Investigational Site Clearwater, Florida, United States

View all 40 locations

View Trial Details